| 1. | Immunopharmacology of rapamycin a review
雷帕霉素的免疫药理学综述 |
| 2. | Rapamycin is indicated as an immunosuppressant for organ rejection in patiens receiving transplantations
研究显示，雷帕霉素可能是接受移植手术病人器官排斥的免疫抑制剂。 |
| 3. | Rapamycin is a critical - dose drug requiring at least monthly monitoring of drug concentrations in the blood
雷帕霉素是一种临界剂量药物，用药后至少需要每月监测血液中药物的浓度。 |
| 4. | Efficacy of rapamycin eluting stent and paclitaxel eluting stent in patients with coronary artery disease and diabetes
冠心病合并糖尿病患者应用雷帕霉素洗脱支架和紫杉醇涂层支架的疗效观察 |
| 5. | A novel , simple and cost effective assay for monitoring blood levels of rapamycin ( sirolimus ) and rapamycin analogues was developed
我们开发了一项用于检测血液中雷帕霉素（西罗莫司）和雷帕霉素类似物浓度的简便、经济节省的新型分析方法。 |
| 6. | There ' s a clear need for a simple effective assay to facilitate monitoring of rapamycyin levels in those patients in which an optimal response needs to be maintained
对于那些要保持最佳反应的病人来说，显然需要一种简单有效的分析方法,提高雷帕霉素水平监测的效率。 |
| 7. | Therefore , newer immunosuppressie agents such as mycophenolate mofetil and sirolimus ( rapa ) hae raised the possibility of withdrawing or aoiding cnis altogether
因此，新的免疫抑制剂如：麦考酚酸吗乙酯和西罗莫司（雷帕霉素）的使用使cni撤退或避免其使用的可行性上升。 |
| 8. | Therefore , newer immunosuppressive agents such as mycophenolate mofetil and sirolimus ( rapa ) have raised the possibility of withdrawing or avoiding cnis altogether
因此，新的免疫抑制剂如：麦考酚酸吗乙酯和西罗莫司（雷帕霉素）的使用使cni撤退或避免其使用的可行性上升。 |
| 9. | Objecties : this study aimed to assess the efficacy of a rapamycin plus 17 - ? - estradiol ? eluting stent ersus a rapamycin - eluting stent in patients with coronary artery disease
目的：该研究的目的是评价联合应用雌二醇和雷帕霉素的药物洗脱支架与单独雷帕霉素支架在冠心病治疗上的效果。 |
| 10. | Background : estradiol promotes rapid re - endothelialization of coronary stents in animal models , but it is not known whether combining this drug with rapamycin represents an improed drug - eluting stent technology in terms of reduced lumen renarrowing
背景：动物实验中，雌二醇可以促进冠脉支架的快速再内皮化，但是联合应用雌二醇和雷帕霉素的药物洗脱支架是否在减少管腔再狭窄方面更加有效，尚不得而知。 |
